TuHURA BIOSCIENCES, INC./NV Payments to Acquire Intangible Assets
TuHURA BIOSCIENCES, INC./NV (HURA) reported Payments to Acquire Intangible Assets of $16.76 thousand for the 9-month period ending 2016-03-31, per its 10-Q filed 2017-05-12.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireIntangibleAssets · last filed 2017-05-12
- TuHURA BIOSCIENCES, INC./NV payments to acquire intangible assets for the quarter ending 2016-03-31 was $0.00.
| Period end | Payments to Acquire Intangible Assets 3 month | Payments to Acquire Intangible Assets 6 month | Payments to Acquire Intangible Assets 9 month |
|---|---|---|---|
| 2016-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-12 | $16.76K 10-Q · filed 2017-05-12 | |
| 2015-12-31 | $16.76K 10-Q · filed 2017-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |